Should Higher Doses of Anti-Hepatitis B Virus (HBV) Therapy Be Considered Post-Liver Transplant (LTx) in HBV DNA Positive Recipients: A Case Report?

被引：0
|
作者：
Patel, Vishal [1 ]
Mukerji, Amar [1 ]
Karachristos, Andreas [1 ]
Maloo, Manoj [1 ]
Jain, Ashokkumar [1 ]
机构：
[1] TUHS, Philadelphia, PA USA
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S167 / S168
页数：2
相关论文
共 50 条
  • [21] Characterization of surface and polymerase gene mutations in hepatitis B virus (HBV) obtained from liver transplant (LT) recipients using the TRUGENE™ HBV Genotyping Kit
    Germer, JJ
    Charlton, MR
    Ishitani, MB
    Patel, R
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1161 - 1161
  • [22] Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core- and anti-hepatitis B surface antibody-positive
    Lau, GKK
    Liang, R
    Lee, CK
    Yuen, ST
    Hou, JL
    Lim, WL
    Williams, R
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06): : 1585 - 1591
  • [23] HEPATITIS-B VIRUS (HBV) DNA AND ASSOCIATED ANTIGENS IN LIVER-TISSUE OF PATIENTS WITH SEVERE ANTI-HBE-POSITIVE CHRONIC HEPATITIS
    DIENES, HP
    GERKEN, G
    GOERGEN, B
    AUTSCHBACH, F
    GERLICH, W
    HEERMANN, F
    ZUMBUSCHENFELDE, KHM
    HEPATOLOGY, 1992, 16 (04) : A200 - A200
  • [24] Usefulness of Liver Biopsy in Anti-Hepatitis C Virus Antibody-Positive and Hepatitis C Virus RNA-Negative Kidney Transplant Recipients
    Kim, So Mi
    Kim, Hyeon Woo
    Lee, Eun-kyoung
    Park, Su Kil
    Han, Duck Jong
    Kim, Soon Bae
    TRANSPLANTATION, 2013, 96 (01) : 85 - 90
  • [25] Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection
    Bocher, WO
    HerzogHauff, S
    Herr, W
    Heermann, K
    Gerken, G
    zumBuschenfelde, KHM
    Lohr, HF
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01): : 52 - 58
  • [26] Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine:: PCR quantitation of HBV DNA and ELISA of preS1 antigen
    Petit, MA
    Buffello-Le-Guillou, D
    Roche, B
    Dussaix, E
    Duclos-Vallée, JC
    Féray, C
    Didier, D
    JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (03) : 493 - 504
  • [27] Survival and risk of hepatitis B virus (HBV) recurrence HIV-HBV coinfected liver transplant recipients: Preliminary findings from the HIV-TR study
    Coffin, Carla S.
    Berg, Carl L.
    Dove, Lorna M.
    Poordad, Fred
    Curry, Michael P.
    Regenstein, Fredric G.
    Sherman, Kenneth E.
    Roland, Michelle E.
    Stock, Peter G.
    Terrault, Norah
    HEPATOLOGY, 2007, 46 (04) : 245A - 246A
  • [28] The detection of (total and ccc) HBV DNA in liver transplant recipients with hepatitis B vaccine against HBV reinfection (Expression of Concern of Vol 11, Pg 2490, 2015)
    Duan, B. W.
    Lu, S. C.
    Lai, W.
    Liu, X. E.
    Liu, Y.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (02) : 615 - 615
  • [29] Anti-virus prophylaxis withdrawal may be feasible in liver transplant recipients whose serum HBeAg and HBV DNA are negative
    Lei Geng
    Bing-Yi Lin
    Tian Shen
    Hua Guo
    Yu-Fu Ye
    Shu-Sen Zheng
    Hepatobiliary&PancreaticDiseasesInternational, 2016, 15 (03) : 316 - 318
  • [30] Anti-virus prophylaxis withdrawal may be feasible in liver transplant recipients whose serum HBeAg and HBV DNA are negative
    Geng, Lei
    Lin, Bing-Yi
    Shen, Tian
    Guo, Hua
    Ye, Yu-Fu
    Zheng, Shu-Sen
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2016, 15 (03) : 316 - 318
12345